Characterization of cell lines resistant to topoisomerase targeting drugs and mechanistic studies of Quinoxaline solid tumor drugs - a new chemical class of topoisomerase II poisons /

Characterization of cell lines resistant to topoisomerase targeting drugs and mechanistic studies of Quinoxaline solid tumor drugs - a new chemical class of topoisomerase II poisons /

Bibliographic Details
Main Author:	Gao, Hanlin
Language:	English
Published:	The Ohio State University / OhioLINK 2001
Subjects:	Health Sciences
Online Access:	http://rave.ohiolink.edu/etdc/view?acc_num=osu1488204276532156

Similar Items

Effects of DNA Geometry and Topoisomerase II Poisons on Human and Bacterial Type II Topoisomerases
by: Ashley, Rachel Erin
Published: (2017)

Stereoselective pharmacokinetics and metabolism of XK469, a new quinoxaline topoisomerase II beta poison, in the rat
by: Zheng, Hui
Published: (2004)

Insights into the Catalytic Mechanism of Eukaryotic and Bacterial Type II Topoisomerases and the Actions of Topoisomerase II Poisons
by: Lindsey, Jr., Robert Hunter
Published: (2015)

Molecular pharmacology of DNA topoisomerase II drugs
by: Lee, Ka Cheong
Published: (2016)

Study of novel dual topoisomerase poisons as potential anti-cancer drugs
by: Lewis, Louisa Joy
Published: (2005)

Synthetic and Natural Products as Poisons of Human Topoisomerase II
by: Ketron, Adam Christopher
Published: (2013)

DNA Lesions as Cellular Poisons of Topoisomerase II-alpha
by: Velez-Cruz, Renier
Published: (2005)

The role of mismatch repair in determining sensitivity to the topoisomerase II poisons
by: Gray, Lisa C.
Published: (2004)

Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.
by: Rachael E Hawtin, et al.
Published: (2010-04-01)

Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
by: Jessica Marinello, et al.
Published: (2018-11-01)

Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy
by: Amol Mehta, et al.
Published: (2018-06-01)

Prognostic Values of Filamin-A Status for Topoisomerase II Poison Chemotherapy
by: Jingyin Yue, Shijie Lan, Changji Yuan, Zhiyuan Shen
Published: (2012-01-01)

DNA topoisomerases as molecular targets for anticancer drugs
by: Kamila Buzun, et al.
Published: (2020-01-01)

INTERACTIONS OF TYPE II TOPOISOMERASES WITH DIVALENT METAL IONS AND THERAPEUTIC DRUGS
by: Pitts, Steven L.
Published: (2011)

A novel class of topoisomerase II poisons containing iron and ruthenium: Anticancer activity and targeted delivery
by: Gopal, Vashisht Y N
Published: (2007)

Quinone Metabolites of Environmental Toxins Poison Topoisomerase IIalpha
by: Bender, Ryan Philip
Published: (2007)

The mechanistic study of isodiospyrin inhibition on human DNA topoisomerase I and IIα
by: Chun-Yuan Ting, et al.
Published: (2003)

Phosphorylation of human topoisomerase II
by: Wells, Nicholas James
Published: (1996)

Topoisomerase II of the malarial parasite
by: Cheesman, Sandra
Published: (1998)

Transcriptional regulation of topoisomerase II
by: Hochhauser, Daniel
Published: (1993)

Anti-topoisomerase drugs as potent inducers of chromosomal aberrations
by: Loredana Bassi, et al.
Published: (2000-12-01)

Characterization of topoisomerase I as a target for chemotherapy: Effect of topoisomerase I poisons and DNA-modifying agents on enzyme activity /
by: Subramanian, Deepa
Published: (1997)

Structural Studies of Human Topoisomerase IIβ and its Interactions with Anticancer Drugs
by: Chyuan-Chuan Wu, et al.
Published: (2013)

Assessment of drug induced genotoxicity in mammalian cells and the contribution of topoisomerase II inhibition
by: Fellows, Michael
Published: (2014)

Myeloperoxidase enhances DNA damage induced by drugs targeting DNA topoisomerase II
by: Atwal, Mandeep
Published: (2017)

Anthracenedione-methionine conjugates as a novel class of topoisomerase II-targeting anticancer drugs with favorable clinical profiles
by: Chieh-Hua Lee, et al.
Published: (2013)

Hypoxia-Targeted Drug Q6 Induces G2-M Arrest and Apoptosis via Poisoning Topoisomerase II under Hypoxia.
by: Linlin Chang, et al.
Published: (2015-01-01)

The role of PARP-1 in the cellular response to topoisomerase I poisons
by: Smith, Lisa Marie
Published: (2004)

Topoisomerase-II mediated biochemical mapping of centromeres and nitroreductase mediated drug metabolism in Trypanosomatids
by: Bot, Christopher
Published: (2012)

Drug Resistance to Topoisomerase Directed Chemotherapy in Human Multiple Myeloma
by: Turner, Joel G
Published: (2008)

Mechanism of cellular response to anticancer drugs : involvement of ATM and topoisomerase /
by: Ju, Rong
Published: (2002)

Effects of topoisomerase I inhibitor evodiamine on drug resistant cells
by: Chien-Chun Yang, et al.
Published: (2012)

Effect of quinolones which target bacterial gyrase and topoisomerase IV on mammalian type II topoisomerases
by: Rance, Holly Ashlene
Published: (2012)

Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues.
by: Thomas D Pfister, et al.
Published: (2012-01-01)

Phosphorylation of the human topoisomerase II protein
by: Fry, Andrew Mark
Published: (1992)

STUDIES OF PORCINE SPLEEN TOPOISOMERASE Ⅱ
by: ZHUANG, JING-KAI, et al.
Published: (1990)

Mechanism of action of putative dual topoisomerase I and II poisons XR5944 and XR11576
by: Jobson, Andrew
Published: (2004)

Characterization of SV40 host range mutants with greatly increased infectivity for human cells and mechanistic studies of XK469-A Novel Anti-Cancer Drug with Topoisomerase II(Beta) Poison Activity /
by: Huang, Kuan-Chun
Published: (2000)

Imatinib enchances the sensitivity of gastrointestinal stromal tumors to topoisomerase II inhibitors
by: S. V. Boichuk, et al.
Published: (2015-06-01)

ROLE OF DNA INTERACTIONS IN MODULATING THE ACTIVITY OF HUMAN TOPOISOMERASES AND ANTICANCER DRUGS
by: Gentry, Amanda Cormine
Published: (2011)